Recent & Archived News
March 07, 2019
Delaro® fungicide raises the bar on yields in first season on the market
The results are in, and in its debut season, fields treated with Delaro® fungicide from Bayer yielded more than the untreated checks. Across the nation, Delaro on average increased corn yield by...
March 05, 2019
The Climate Corporation and NAU Country Insurance Company Partner to Enable Seamless Crop Insurance Reporting for U.S. Farmers
The Climate Corporation (Climate), a subsidiary of Bayer, announced today a platform agreement between the company's industry-leading Climate FieldView™ digital agriculture platform and NAU...
February 27, 2019
Bayer completes rolling submission of New Drug Application to U.S. Food and Drug Administration for investigational drug darolutamide for the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC)
Bayer today announced the completion of the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the investigational drug darolutamide. The...
February 26, 2019
Open Dialogue and Transparency Drive Progress in Modern Agriculture and Consumer Acceptance
People around the world seem to be more divided on important food and agricultural topics than ever before. The use of on-farm technologies, breakthroughs like CRISPR, and how to address...
February 21, 2019
'Wall Smashing' Ceremony Initiates Construction Of Bayer Funded Geospatial Innovation And Resource Center at T-REX Business Incubator
Sledgehammers breaking through a mock wall signaled the construction start of the new 'Geosaurus, Powered by Bayer' Innovation Resource Center at T-REX, a St. Louis based advanced technology...
February 15, 2019
Bayer to obtain full rights to global development and commercialization of oncology compounds Vitrakvi® (larotrectinib) and BAY 2731954 (LOXO-195)
Bayer has exercised its option, under a change-in-control clause in the collaboration agreement with Loxo Oncology, to obtain the exclusive licensing rights for the global development and...
February 14, 2019
Bayer's investigational drug darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free survival compared to placebo plus ADT in non-metastatic castration-resistant prostate cancer
Results from the pivotal Phase III ARAMIS trial in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) showed a statistically significant improvement in metastasis-free...
February 13, 2019
Bayer donates $130,000 to 13 domestic violence shelters through new Grants Fur Families program
Bayer announces 13 domestic violence shelters that are receiving funding through Grants Fur Families, a new program providing life-saving support to domestic violence shelters across the country...
February 13, 2019
Bayer and Geisinger partner to create contraception counseling pathway to improve overall contraceptive care for women
Bayer, a longstanding leader in women's healthcare, and Geisinger are partnering to create a contraception counseling pathway within the Geisinger Electronic Health Record (EHR) with the aim of...
February 07, 2019
Bayer's Ray Kerins Elected Chairman of U.S. Chamber of Commerce's Global Innovation Policy Center
Bayer U.S. announced today that Raymond F. Kerins, Jr., Senior Vice President of Corporate Affairs, is the new Chairman of the U.S. Chamber of Commerce's Global Innovation Policy Center (GIPC). In...
Want even more Bayer news?
Last Updated: December 14, 2018